🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
17.58
-0.96 (-5.18%)
At close: Nov 20, 2026, 4:00 PM EST
18.00
+0.42 (2.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

Caris Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
665.32796.2763.9556.4107.19
Short-Term Investments
102.062.32.265.18302.43
Cash & Short-Term Investments
767.38798.5766.15121.59409.62
Cash Growth
1.57%1107.19%-45.59%-70.32%-
Receivables
133.32112.1488.2455.340.23
Inventory
138.3763.6339.574946.96
Prepaid Expenses
23.2819.5913.5611.7713.36
Restricted Cash
-1.531.493.613.95
Other Current Assets
4.912.366.711.361.93
Total Current Assets
1,067997.8215.73242.61516.04
Property, Plant & Equipment
102.3103.02102.77147.51179.19
Goodwill
19.3419.3419.3419.3419.34
Other Long-Term Assets
66.725.55.893.432.85
Total Assets
1,2561,126343.73412.9717.42

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
63.8439.2127.7926.6827.27
Accrued Expenses
70.3656.9263.9955.6851.11
Current Portion of Long-Term Debt
0.09-60-52.04
Current Portion of Leases
6.296.536.176.595.05
Current Unearned Revenue
18.3724.497.475.681.43
Other Current Liabilities
---0.51-
Total Current Liabilities
158.95127.15165.4295.14136.91
Long-Term Debt
393.18378.45319.2166.11169.09
Long-Term Leases
63.4742.7138.8944.4144.69
Other Long-Term Liabilities
-0.0597.41126.91114.68
Total Liabilities
616.14548.36620.92432.57465.36

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
0.290.280.040.040.14
Additional Paid-In Capital
3,1743,142---
Retained Earnings
-2,535-2,549-2,472-2,119-1,679
Treasury Stock
--16.9-0.33-0.33-0.33
Comprehensive Income & Other
-0.110.94-26.25-25.48-23.27
Total Common Equity
639.48577.31-2,499-2,145-1,702
Shareholders' Equity
639.48577.31-277.19-19.67252.06
Total Liabilities & Equity
1,2561,126343.73412.9717.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
463.02427.69424.26217.11270.87
Net Cash (Debt)
304.36370.88-358.11-95.52138.75
Net Cash Growth
-7.42%----
Net Cash Per Share
1.042.22-10.09-2.734.16
Filing Date Shares Outstanding
286.78282.58277.9335.1133.37
Total Common Shares Outstanding
286.72282.5336.535.1133.37
Working Capital
908.32870.6650.31147.47379.14
Book Value Per Share
2.232.04-68.45-61.08-51.01
Tangible Book Value
620.14557.96-2,518-2,164-1,721
Tangible Book Value Per Share
2.161.97-68.98-61.63-51.59
Machinery
243.71212.44207.47224.65210.05
Leasehold Improvements
67.8163.8163.0466.5863.1
SEC Filings: 10-K · 10-Q